English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 96 | Tables: 89 | Pharma & Healthcare
The global market for Vaccines was valued at US$ 50450 million in the year 2024 and is projected to reach a revised size of US$ 73490 million by 2031, growing at a CAGR of 5.6% during the forecast period.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Vaccines Market Overview
1.1 Product Definition
1.2 Vaccines by Type
1.2.1 Global Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines by Application
1.3.1 Global Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Global Vaccines Market Size Estimates and Forecasts
1.4.1 Global Vaccines Revenue 2020-2031
1.4.2 Global Vaccines Sales 2020-2031
1.4.3 Global Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccines Market Competition by Manufacturers
2.1 Global Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Vaccines, Date of Enter into This Industry
2.8 Global Vaccines Market Competitive Situation and Trends
2.8.1 Global Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccines Players Market Share by Revenue
2.8.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccines Market Scenario by Region
3.1 Global Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccines Sales by Region: 2020-2031
3.2.1 Global Vaccines Sales by Region: 2020-2025
3.2.2 Global Vaccines Sales by Region: 2026-2031
3.3 Global Vaccines Revenue by Region: 2020-2031
3.3.1 Global Vaccines Revenue by Region: 2020-2025
3.3.2 Global Vaccines Revenue by Region: 2026-2031
3.4 North America Vaccines Market Facts & Figures by Country
3.4.1 North America Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccines Sales by Country (2020-2031)
3.4.3 North America Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccines Market Facts & Figures by Country
3.5.1 Europe Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccines Sales by Country (2020-2031)
3.5.3 Europe Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vaccines Market Facts & Figures by Country
3.7.1 Latin America Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines Sales by Type (2020-2031)
4.1.1 Global Vaccines Sales by Type (2020-2025)
4.1.2 Global Vaccines Sales by Type (2026-2031)
4.1.3 Global Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Vaccines Revenue by Type (2020-2031)
4.2.1 Global Vaccines Revenue by Type (2020-2025)
4.2.2 Global Vaccines Revenue by Type (2026-2031)
4.2.3 Global Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccines Sales by Application (2020-2031)
5.1.1 Global Vaccines Sales by Application (2020-2025)
5.1.2 Global Vaccines Sales by Application (2026-2031)
5.1.3 Global Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Vaccines Revenue by Application (2020-2031)
5.2.1 Global Vaccines Revenue by Application (2020-2025)
5.2.2 Global Vaccines Revenue by Application (2026-2031)
5.2.3 Global Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novartis(GSK)
6.5.1 Novartis(GSK) Company Information
6.5.2 Novartis(GSK) Description and Business Overview
6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis(GSK) Vaccines Product Portfolio
6.5.5 Novartis(GSK) Recent Developments/Updates
6.6 CSL
6.6.1 CSL Company Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Vaccines Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.7.1 MedImmune LLC Company Information
6.7.2 MedImmune LLC Description and Business Overview
6.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MedImmune LLC Vaccines Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Company Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 J&J(Crucell) Vaccines Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Company Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 China National Biotec Vaccines Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Company Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tiantan Vaccines Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Company Information
6.11.2 Hualan Description and Business Overview
6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Vaccines Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Company Information
6.12.2 Kangtai Description and Business Overview
6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kangtai Vaccines Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Company Information
6.13.2 Hissen Description and Business Overview
6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hissen Vaccines Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 Jintan
6.14.1 Jintan Company Information
6.14.2 Jintan Description and Business Overview
6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Jintan Vaccines Product Portfolio
6.14.5 Jintan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines Industry Chain Analysis
7.2 Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines Production Mode & Process Analysis
7.4 Vaccines Sales and Marketing
7.4.1 Vaccines Sales Channels
7.4.2 Vaccines Distributors
7.5 Vaccines Customer Analysis
8 Vaccines Market Dynamics
8.1 Vaccines Industry Trends
8.2 Vaccines Market Drivers
8.3 Vaccines Market Challenges
8.4 Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Vaccines Price (USD/Unit) by Type (2020-2025)
Table 59. Global Vaccines Price (USD/Unit) by Type (2026-2031)
Table 60. Global Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Vaccines Price (USD/Unit) by Application (2020-2025)
Table 69. Global Vaccines Price (USD/Unit) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. GSK Vaccines Product
Table 74. GSK Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Vaccines Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Vaccines Product
Table 84. Merck Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Vaccines Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Novartis(GSK) Company Information
Table 91. Novartis(GSK) Description and Business Overview
Table 92. Novartis(GSK) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Novartis(GSK) Vaccines Product
Table 94. Novartis(GSK) Recent Developments/Updates
Table 95. CSL Company Information
Table 96. CSL Description and Business Overview
Table 97. CSL Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. CSL Vaccines Product
Table 99. CSL Recent Developments/Updates
Table 100. MedImmune LLC Company Information
Table 101. MedImmune LLC Description and Business Overview
Table 102. MedImmune LLC Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. MedImmune LLC Vaccines Product
Table 104. MedImmune LLC Recent Developments/Updates
Table 105. J&J(Crucell) Company Information
Table 106. J&J(Crucell) Description and Business Overview
Table 107. J&J(Crucell) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. J&J(Crucell) Vaccines Product
Table 109. J&J(Crucell) Recent Developments/Updates
Table 110. China National Biotec Company Information
Table 111. China National Biotec Description and Business Overview
Table 112. China National Biotec Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. China National Biotec Vaccines Product
Table 114. China National Biotec Recent Developments/Updates
Table 115. Tiantan Company Information
Table 116. Tiantan Description and Business Overview
Table 117. Tiantan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Tiantan Vaccines Product
Table 119. Tiantan Recent Developments/Updates
Table 120. Hualan Company Information
Table 121. Hualan Description and Business Overview
Table 122. Hualan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Hualan Vaccines Product
Table 124. Hualan Recent Developments/Updates
Table 125. Kangtai Company Information
Table 126. Kangtai Description and Business Overview
Table 127. Kangtai Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Kangtai Vaccines Product
Table 129. Kangtai Recent Developments/Updates
Table 130. Hissen Company Information
Table 131. Hissen Description and Business Overview
Table 132. Hissen Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Hissen Vaccines Product
Table 134. Hissen Recent Developments/Updates
Table 135. Jintan Company Information
Table 136. Jintan Description and Business Overview
Table 137. Jintan Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Jintan Vaccines Product
Table 139. Jintan Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Vaccines Distributors List
Table 143. Vaccines Customers List
Table 144. Vaccines Market Trends
Table 145. Vaccines Market Drivers
Table 146. Vaccines Market Challenges
Table 147. Vaccines Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccines
Figure 2. Global Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccines Market Share by Type: 2024 & 2031
Figure 4. Recombinant Vaccines Product Picture
Figure 5. Viral Vaccines Product Picture
Figure 6. Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Vaccines Market Share by Application: 2024 & 2031
Figure 10. Rabies vaccine
Figure 11. Influenza vaccine
Figure 12. HPV vaccine
Figure 13. Hepatitis B
Figure 14. Hepatitis A
Figure 15. Leprosy vaccine
Figure 16. Polio vaccine
Figure 17. JE vaccine
Figure 18. Others
Figure 19. Global Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Vaccines Market Size (2020-2031) & (US$ Million)
Figure 21. Global Vaccines Sales (2020-2031) & (K Units)
Figure 22. Global Vaccines Average Price (USD/Unit) & (2020-2031)
Figure 23. Vaccines Report Years Considered
Figure 24. Vaccines Sales Share by Manufacturers in 2024
Figure 25. Global Vaccines Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest Vaccines Players: Market Share by Revenue in Vaccines in 2024
Figure 27. Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America Vaccines Sales Market Share by Country (2020-2031)
Figure 30. North America Vaccines Revenue Market Share by Country (2020-2031)
Figure 31. U.S. Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe Vaccines Sales Market Share by Country (2020-2031)
Figure 34. Europe Vaccines Revenue Market Share by Country (2020-2031)
Figure 35. Germany Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Vaccines Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific Vaccines Revenue Market Share by Region (2020-2031)
Figure 42. China Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. China Taiwan Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Indonesia Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Thailand Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Malaysia Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Latin America Vaccines Sales Market Share by Country (2020-2031)
Figure 52. Latin America Vaccines Revenue Market Share by Country (2020-2031)
Figure 53. Mexico Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Brazil Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Argentina Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Vaccines Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Vaccines Revenue Market Share by Country (2020-2031)
Figure 58. Turkey Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. UAE Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Global Sales Market Share of Vaccines by Type (2020-2031)
Figure 62. Global Revenue Market Share of Vaccines by Type (2020-2031)
Figure 63. Global Vaccines Price (USD/Unit) by Type (2020-2031)
Figure 64. Global Sales Market Share of Vaccines by Application (2020-2031)
Figure 65. Global Revenue Market Share of Vaccines by Application (2020-2031)
Figure 66. Global Vaccines Price (USD/Unit) by Application (2020-2031)
Figure 67. Vaccines Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
